Table 2.

Gene nameGene symbolMapAccession no.CGH analysis ratioExpression analysis t (P)
A. Amplified and overexpressed genes
    Clear cell adenocarcinoma
        Neurogranin (protein kinase C substrate, RC3)NRGN11q24NM_0061763.032.78 (0.004)
        ADP-ribosyltransferase 3ART34p15.1-p14NM_0011792.683.37 (0.01)
        ATP-binding cassette, subfamily F (GCN20)ABCF27q35-q36NM_0071892.582.21 (0.02)
        Zinc finger protein 207ZNF20717q11.2NM_0034572.273.55 (<0.001)
        Cytochrome P450, subfamily VII, subfamilyCYP7B18q21.3NM_0048201.652.46 (0.001)
        KIAA1140 proteinKIAA11402p21AK_0467401.592.15 (0.002)
        Leucine zipper–like transcriptional regulator 1LZTR122q11.21NM_0067671.484.94 (<0.001)
        Hypoxia-inducible protein 2HIG27q32.2NM_0133321.482.11 (0.021)
        Kinesin family member 5AKIF5A12q13NM_0049841.472.88 (0.004)
        ATPase, Na+/K+ transporting, β3 polypeptideATP1B33q22-q23NM_0016791.432.18 (0.018)
        Transcription factor 21TCF216q23NM_1983921.422.62 (0.007)
        KIAA0955 proteinKIAA095519q13.33AB_0231721.412.12 (0.002)
    Serous cystadenocarcinomas
        Interleukin-15 receptor, αIL15RA10p15-p14NM_0021892.20−2.23 (0.017)
        Hepatocyte nuclear factor 3, αHNF3A14q12-q13NM_0044961.93−3.06 (0.002)
        Small proline-rich protein SPRKSPRK1q21AW_1352261.49−2.50 (0.009)
        Cysteine-rich protein 1 (intestinal)CRIP17q11.23NM_0013111.44−2.93 (0.003)
        Podocalyxin-likePODXL7q32-q33NM_0053971.42−2.95 (0.003)
        GCIP-interacting protein p29p291p36.13-p35.1NM_0154841.42−2.61 (0.007)
        Neuron-specific proteinD4S234E4p16.3NM_0143921.41−2.21 (0.017)
        DKFZP564D177 proteinNIPSNAP3A9q31NM_0154691.41−2.71 (0.005)
B. Deleted and underexpressed genes
    Clear cell adenocarcinoma
        Kallikrein 6 (neurosin, zyme)KLK619q13.3NM_00027740.63−3.22 (0.002)
        KIAA0575 gene productGREB12p25.1NM_1489030.69−2.90 (0.003)
        ESTs12q24.10.69−3.72 (<0.001)
        PrepronociceptinPNOC8q21NM_0062280.71−3.87 (<0.001)
        ESTs19q13.40.71−3.30 (0.001)
    Serous cystadenocarcinomas
        Fibrinogen, A α polypeptideFGA4q28NM_0005080.092.28 (0.015)
        Meningioma expressed antigen 6MGEA614q13.3NM_2033560.124.07 (<0.001)
        Aldo-keto reductase family 1, member C4AKR1C410p15-p14NM_0018180.123.97 (<0.001)
        Ligase III, DNA, ATP dependentLIG317q11.2-q12NM_0139750.133.66 (0.001)
        Methyl-CpG-binding domain protein 1MBD118q21NM_0158460.182.71 (0.005)
        Retinol-binding protein 4, plasmaRBP410q23-q24NM_0067440.203.28 (0.001)
        Insulin-like growth factor 1 receptorIGF1R15q26.3NM_0008750.222.62 (0.007)
        Insulin-degrading enzymeIDE10q23-q25NM_0049690.242.21 (0.017)
        Glypican 3GPC3Xq26.1NM_0044840.263.01 (0.003)
        Spectrin, β, nonerythrocytic 1SPTBN12p21NM_0031280.28322 (0.001)
        LIM and senescent cell antigen-like domains 1LIMS12q12.3NM_0049870.292.22 (0.017)
        Mutated in colorectal cancersMCC5q21-q22NM_0023870.292.11 (0.022)
        Carboxypeptidase MCPM12q15NM_0018740.293.16 (0.002)
        Hexosaminidase A (α polypeptide)HEXA15q23-q24NM_0005200.292.40 (0.01)
        Homo sapiens mRNA; cDNA DKFZp434K152DKFZp434K1521p34.2AL_1574610.302.42 (0.01)
  • NOTE: t = [log2(clear cell) − log2(serous)] / SE[log2(clear cell) − log2(serous)].